• 1
    Hearp ML,Locante AM,Ben-Rubin M,Dietrich R,David O. Validity of sampling error as a cause of noncorrelation. Cancer. 2007; 111: 275-279.
  • 2
    SolomonD, NayarR, eds. The Bethesda System for Reporting Cervical Cytology.2nd ed. New York, NY: Springer-Verlag; 2004.
  • 3
    Cramer H,Schlenk E. An analysis of discrepancies between the cervical cytologic diagnosis and subsequent histopathologic diagnosis in 1260 cases [abstract]. Acta Cytol. 1994; 39: 812.
  • 4
    Ibrahim SN,Krigman HR,Coogan AC, et al. Prospective correlation of cervicovaginal cytologic and histologic specimens. Am J Clin Pathol. 1996; 106: 319-324.
  • 5
    Jones BA,Novis DA. Cervical biopsy–cytology correlation. A College of American Pathologists Q-Probes study of 22,439 correlations in 348 laboratories. Arch Pathol Lab Med. 1996; 120: 523-531.
  • 6
    Joste NE,Crum CP,Cibas ES. Cytologic/histologic correlation for quality control in cervicovaginal cytology: experience with 1,582 paired cases. Am J Clin Pathol. 1995; 103: 32-34.
  • 7
    Rohr LR. Quality assurance in gynecologic cytology: what is practical? Am J Clin Pathol. 1990; 94: 754-758.
  • 8
    Branca M,Ciotti M,Santini D, et al. p16(Ink4a) expression is related to grade of CIN and high-risk human papillomavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol. 2004; 23: 354-365.
  • 9
    von Knebel Doeberitz M. New molecular tools for efficient screening of cervical cancer. Dis Markers. 2001; 17: 123-128.
  • 10
    Duncan L,Jacob S,Hubbard E. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance. Cancer. 2008; 114: 34-48.
  • 11
    Monsonego J,Pollini G,Evrard MJ, et al. p16(Ink4a) immunocytochemistry in liquid-based cytology samples in equivocal Pap smears: added value in management of women with equivocal Pap smear. Acta Cytol. 2007; 51: 755-766.
  • 12
    TriPath Molecular Oncology. Available at: Accessed on June 1, 2008.
  • 13
    Tambouret RH,Misdraji J,Wilbur DC. Longitudinal clinical evaluation of a novel antibody cocktail for detection of high-grade squamous intraepithelial lesions on cervical cytology specimens. Arch Pathol Lab Med. 2008; 132: 918-925.
  • 14
    Badr RE,Walts AE,Chung F,Bose S. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix. Am J Surg Pathol. 2008; 32: 899-906.
  • 15
    Shi J,Liu H,Wilkerson M, et al. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEX C, and p16INK4a/ProEX C in cervical squamous intraepithelial lesions. Hum Pathol. 2007; 38: 1335-1344.
  • 16
    Ferris DG,Litaker MS,ALTS Group. Prediction of cervical histologic results using an abbreviated Reid Colposcopic Index during ALTS. Am J Obstet Gynecol. 2006; 194: 704-710.
  • 17
    Bonvicino A,Huitron S,Fadare O. Papanicolaou test interpretations of “atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion”: an investigation of requisite duration and number of colposcopic procedures to a definitive diagnosis of high-grade dysplasia in routine practice. Cancer (Cancer Cytopathol). 2007; 111: 477-481.
  • 18
    Melnikow J,Nuovo J,Willan AR,Chan BK,Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol. 1998; 92(4 pt 2): 727-735.
  • 19
    Hammes LS,Naud P,Passos EP, et al. Value of the International Federation for Cervical Pathology and Colposcopy (IFCPC) terminology in predicting cervical disease. J Low Genit Tract Dis. 2007; 11: 158-165.